| 1 |
33033903 | Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and Zidovudine. | 2020 Oct 8 |
1 |
| 2 |
30921829 | Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulation. | 2019 Apr |
1 |
| 3 |
30443442 | The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety. | 2018 Aug 13 |
1 |
| 4 |
27622723 | Implication of UGT2B15 Genotype Polymorphism on Postoperative Anxiety Levels in Patients Receiving Lorazepam Premedication. | 2016 Nov |
5 |
| 5 |
17687269 | Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. | 2008 Apr |
1 |
| 6 |
15961980 | Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. | 2005 Jun |
2 |